Junyu Liang

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Targeting RIPK1 is a promising therapeutic avenue for systemic lupus erythematosus.

Targeting RIPK1 is a promising therapeutic avenue for systemic lupus erythematosus.

Journal: Clinical rheumatology

Published: July 11, 2025

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.

Journal: Clinical and experimental rheumatology

Published: April 09, 2025

Volume-Based Quantitative Measurement of [18F]AlF-NOTA-FAPI-04 PET/CT Uptake Reflects the Disease Activity of IgG4-Related Disease.

Volume-Based Quantitative Measurement of [18F]AlF-NOTA-FAPI-04 PET/CT Uptake Reflects the Disease Activity of IgG4-Related Disease.

Journal: Molecular imaging and biology

Published: January 01, 2024

Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series studyAmbrisentan for digital ulcers.

Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series studyAmbrisentan for digital ulcers.

Journal: The Journal of dermatological treatment

Published: December 11, 2023

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.

Journal: Journal of translational internal medicine

Published: August 03, 2023

An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients.

An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients.

Journal: Clinical rheumatology

Published: May 12, 2023

Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial.

Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial.

Journal: PLoS medicine

Published: January 23, 2023

The potential role of 18 F-FDG PET/CT in dermatomyositis with cardiac involvement: A case report.

The potential role of 18 F-FDG PET/CT in dermatomyositis with cardiac involvement: A case report.

Journal: International journal of rheumatic diseases

Published: August 18, 2022

The Role of Advanced Imaging in Gout Management.

The Role of Advanced Imaging in Gout Management.

Journal: Frontiers in immunology

Published: November 08, 2021

Radiological Characteristics of Patients With Anti-MDA5-Antibody-Positive Dermatomyositis in 18F-FDG PET/CT: A Pilot Study.

Radiological Characteristics of Patients With Anti-MDA5-Antibody-Positive Dermatomyositis in 18F-FDG PET/CT: A Pilot Study.

Journal: Frontiers in medicine

Published: September 18, 2021

DAP10 Predicted the Outcome of Pediatric B-Cell Acute Lymphoblastic Leukemia and Was Associated with the T-Cell Exhaustion.

DAP10 Predicted the Outcome of Pediatric B-Cell Acute Lymphoblastic Leukemia and Was Associated with the T-Cell Exhaustion.

Journal: Journal of oncology

Published: September 13, 2021

Clinical Value of 18F-FDG PET/CT Scan and Cytokine Profiles in Secondary Hemophagocytic Lymphohistiocytosis in Idiopathic Inflammatory Myopathy Patients: A Pilot Study.

Clinical Value of 18F-FDG PET/CT Scan and Cytokine Profiles in Secondary Hemophagocytic Lymphohistiocytosis in Idiopathic Inflammatory Myopathy Patients: A Pilot Study.

Journal: Frontiers in immunology

Published: September 07, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026